22 HARTFORDBUSINESS.COM | JANUARY 31, 2022
RNs
|
LPNs
|
CNAs
|
Respiratory Therapists
bristolhealth.org/hiring
Bristol Health is looking for YOU – an
EXCEPTIONAL
healthcare worker
As an integrated delivery network with deep roots in the
community, we make a critical impact on the people we serve.
Not only do we want our patients to live their best lives, but
we also want our employees and their families to have the
resources they need to thrive. When you work here, you can
feel confident in knowing that you're making a difference in a
place that supports you personally and professionally.
Join the team that's delivering healthcare the way it should be!
FOR ADVERTISING INFORMATION CALL 860.236.9998 OR EMAIL
ADVERTISING@HARTFORDBUSINESS.COM
Be a part of this special
publication highlighting the
who's who of the Greater Hartford
Business, political, higher-
education & nonprofit elite.
ADVERTISING DEADLINE: 2/14
PUBLICATION DATE: 2/28
FOCUS: HEALTH CARE
By Robert Storace
rstorace@hartfordbusiness.com
A
member of UConn's
Technology Incubation
Program since 2017,
Ashley Kalinauskas'
veterinary pharmaceutical
startup Torigen Pharmaceuticals Inc.
is getting ready to venture out on its
own.
The company, which is developing
a cancer vaccine for animals, has
raised $7.7 million to date, most of
it in the last two years, and recently
signed a 9,090-square-foot lease
in Farmington, at 6 Executive Dr.,
where it will move its operations by
summer.
Kalinauskas, Torigen's 31-year-
old founder and CEO, has seen
early promise with an animal
cancer vaccine called VetiVax. The
vaccine was invented in 2006 at
the University of Notre Dame by
then-researcher and professor Mark
Suckow, who is now Torigen's
chief technology officer.
The VetiVax vaccine, which has
eight patents owned by Notre Dame
and licensed to Torigen, is regulated
by the U.S. Department of Agriculture
(USDA) Center of Veterinary
Biologics as an experimental therapy
with unproven safety and efficacy,
but the company is working toward
obtaining conditional licensure. It
would need to go through clinical
Pet cancer vaccine maker Torigen Pharmaceuticals
expanding with new lease, venture funding
Ashley Kalinauskas is the 31-year-old founder and CEO of Torigen Pharmaceuticals, which is developing an animal cancer vaccine called VetiVax.
HBJ
PHOTO
|
STEVE
LASCHEVER
